NCT01502020 · Interventional trial
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
Overall registry status Completed
Conditions Actinic Keratoses
Delaware Valley sites
- Philadelphia Institute of Dermatology · Fort Washington, PA · Montgomery County
First posted
Registry updated
Added to the directory